
Welcome to ERSO | erso
ERSO is a central administrative hub providing comprehensive research and administrative services to the College of Engineering, College of Environmental Design, Computing, Data Science & Society, Mathematical & Physical Sciences Division, School of Information, and various large research Institutes and Centers.
A small-molecule activator of the unfolded protein response
2021年7月21日 · Metastatic estrogen receptor α (ERα)-positive breast cancer is presently incurable. Seeking to target these drug-resistant cancers, we report the discovery of a compound, called ErSO, that activates the anticipatory unfolded protein response (a-UPR) and induces rapid and selective necrosis of ERα-po …
Jyn Erso Thanh Ho (@jynthewheatie) • Instagram photos and videos
145 Followers, 122 Following, 9 Posts - Jyn Erso Thanh Ho (@jynthewheatie) on Instagram: "Named after the heroine in Rogue One AKC Wheaten/Endorian Terrier 1/15/21 3/13/21 San Diego Bay Area Dad: @vhoyouknow"
Solar and Heliospheric Observatory Homepage
1 天前 · The April 8, 2024, total solar eclipse crossed North America, passing over Mexico, the United States, and Canada... more » JHelioviewer is new visualization software that enables …
打破肿瘤的“保护伞”,将耐药和转移一网打尽|雌激素受体|ErSO|基 …
2021年8月12日 · 新发现的小分子化合物erso,具有选择性乳腺癌细胞杀伤作用,且只对雌激素受体(erα)阳性的乳腺癌有效。 erso对初治和内分泌治疗耐药的erα阳性乳腺癌均有效。 erso对原位和转移的erα阳性乳腺癌均有效,包括脑转移的乳腺癌。
ERSO
ERSO is a multidisciplinary integrated company focused on comprehensive equipment and implementation of projects of new construction, reconstruction and modernization of power facilities.
Science子刊:击败耐药性,根除癌细胞!无复发、无转移的乳腺癌 …
美国伊利诺伊大学香槟分校的研究团队在 Science Translational Medicine 发表最新研究 A small-molecule activator of the unfolded protein response eradicates human breast tumors in mice ,研究指出,此次研究发现的新型分子化合物 ErSO 能与乳腺癌细胞上的雌激素受体结合,增强癌细胞 …
Science子刊:击败耐药性,根除癌细胞!无复发、无转移的乳腺癌 …
2021年7月26日 · ErSO能够快速破坏大多数肺、骨和肝转移灶,并使脑转移灶急剧缩小. 此次研究中的小分子新药ErSO,不仅能够诱导肿瘤消退,防止癌症复发与转移,还能够抑制肿瘤耐药性的出现。在该项研究中100多只接受ErSO治疗的小鼠体内,研究人员均未观察到ErSO耐药肿瘤。
拜耳2500万美元获得的乳腺癌新药效果优异:95%以上癌细胞被杀死
2021年7月24日 · ErSO由Systems Oncology研发,用于治疗转移性雌激素受体阳性乳腺癌。 在7月22日Science Translational Medicine发表的最新论文中,实验结果显示ErSO能杀死小鼠模型中95%-100%的癌细胞,而且药物还显著减少了肺、骨和脑部的癌转移。
ERSO (System Oncology)(ERSO (System Oncology)) - 药物靶 …
We recently reported ErSO, a compound that induces ERα-dependent cancer cell death through a mechanism distinct from clinically approved ERα drugs, via hyperactivation of the anticipatory unfolded protein response. ErSO has remarkable tumor-eradicative activity in …
- 某些结果已被删除